1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. Research Methodology
1.2.1 Secondary Research
1.2.2 Data Analysis Framework
1.2.3 Market size estimation
1.2.4 Forecasting
1.2.5 Primary Research and Data Validation
2.MARKET SNAPSHOT, 2019-2030 Million USD
2.1. MARKET SNAPSHOT
3.PORTER’S FIVE FORCE MODEL ANALYSIS
4.MARKET DYNAMICS
4.1. GROWTH DRIVERS
4.1.1 DRIVER 1
4.1.2 DRIVER 2
4.1.3 DRIVER 3
4.1.4 DRIVER 4
4.2. CHALLENGES
4.2.1 CHALLENGE 1
4.2.2 CHALLENGE 2
4.3. OPPORTUNITIES
4.3.1 OPPORTUNITY 1
4.3.2 OPPORTUNITY 2
5.Global Early Toxicity Testing Market, By Technique
5.1. Overview
5.2. In Vivo
5.2.1 In Vivo Market, By Region
5.2.1.1 North America In Vivo Market, By Country
5.2.1.2 Europe In Vivo Market, By Country
5.2.1.3 Asia-Pacific In Vivo Market, By Country
5.2.1.4 Rest of World In Vivo Market, By Country
5.3. In Vitro
5.3.1 Global In Vitro Market, By Technique
5.3.1.1 Assays Market, By Region
5.3.1.1.1 North America Assays Market, By Country
5.3.1.1.2 Europe Assays Market, By Country
5.3.1.1.3 Asia-Pacific Assays Market, By Country
5.3.1.1.4 Rest of World Assays Market, By Country
5.3.1.2 Toxicity End points Market, By Region
5.3.1.2.1 North America Toxicity End points Market, By Country
5.3.1.2.2 Europe Toxicity End points Market, By Country
5.3.1.2.3 Asia-Pacific Toxicity End points Market, By Country
5.3.1.2.4 Rest of World Toxicity End points Market, By Country
5.3.2 In Vitro Market, By Region
5.3.2.1 North America In Vitro Market, By Country
5.3.2.2 Europe In Vitro Market, By Country
5.3.2.3 Asia-Pacific In Vitro Market, By Country
5.3.2.4 Rest of World In Vitro Market, By Country
5.4. In Silico
5.4.1 In Silico Market, By Region
5.4.1.1 North America In Silico Market, By Country
5.4.1.2 Europe In Silico Market, By Country
5.4.1.3 Asia-Pacific In Silico Market, By Country
5.4.1.4 Rest of World In Silico Market, By Country
6. Global Early Toxicity Testing Market, By End User
6.1. Overview
6.2. Pharmaceuticals Industry
6.2.1 Pharmaceuticals Industry Market, By Region
6.2.1.1 North America Pharmaceuticals Industry Market, By Country
6.2.1.2 Europe Pharmaceuticals Industry Market, By Country
6.2.1.3 Asia-Pacific Pharmaceuticals Industry Market, By Country
6.2.1.4 Rest of World Pharmaceuticals Industry Market, By Country
6.3. Diagnostics Industry
6.3.1 Diagnostics Industry Market, By Region
6.3.1.1 North America Diagnostics Industry Market, By Country
6.3.1.2 Europe Diagnostics Industry Market, By Country
6.3.1.3 Asia-Pacific Diagnostics Industry Market, By Country
6.3.1.4 Rest of World Diagnostics Industry Market, By Country
6.4. Food Industry
6.4.1 Food Industry Market, By Region
6.4.1.1 North America Food Industry Market, By Country
6.4.1.2 Europe Food Industry Market, By Country
6.4.1.3 Asia-Pacific Food Industry Market, By Country
6.4.1.4 Rest of World Food Industry Market, By Country
6.5. Chemicals Industry
6.5.1 Chemicals Industry Market, By Region
6.5.1.1 North America Chemicals Industry Market, By Country
6.5.1.2 Europe Chemicals Industry Market, By Country
6.5.1.3 Asia-Pacific Chemicals Industry Market, By Country
6.5.1.4 Rest of World Chemicals Industry Market, By Country
6.6. Cosmetics Industry
6.6.1 Cosmetics Industry Market, By Region
6.6.1.1 North America Cosmetics Industry Market, By Country
6.6.1.2 Europe Cosmetics Industry Market, By Country
6.6.1.3 Asia-Pacific Cosmetics Industry Market, By Country
6.6.1.4 Rest of World Cosmetics Industry Market, By Country
6.7. Others
6.7.1 Others Market, By Region
6.7.1.1 North America Others Market, By Country
6.7.1.2 Europe Others Market, By Country
6.7.1.3 Asia-Pacific Others Market, By Country
6.7.1.4 Rest of World Others Market, By Country
7. Global Early Toxicity Testing Market, By Region
7.1. Overview
7.2. North America
7.2.1 North America Early Toxicity Testing Market, By Technique
7.2.1.1 North America In Vitro Market, By Technique
7.2.2 North America Early Toxicity Testing Market, By End User
7.2.3 North America Early Toxicity Testing, Market By Country
7.2.3.1 U.S.
7.2.3.1.1 U.S. Early Toxicity Testing Market, By Technique
7.2.3.1.1.1. U.S. In Vitro Market, By Technique
7.2.3.1.2 U.S. Early Toxicity Testing Market, By End User
7.2.3.2 Canada
7.2.3.2.1 Canada Early Toxicity Testing Market, By Technique
7.2.3.2.1.1. Canada In Vitro Market, By Technique
7.2.3.2.2 Canada Early Toxicity Testing Market, By End User
7.2.3.3 Mexico
7.2.3.3.1 Mexico Early Toxicity Testing Market, By Technique
7.2.3.3.1.1. Mexico In Vitro Market, By Technique
7.2.3.3.2 Mexico Early Toxicity Testing Market, By End User
7.3. Europe
7.3.1 Europe Early Toxicity Testing Market, By Technique
7.3.1.1 Europe In Vitro Market, By Technique
7.3.2 Europe Early Toxicity Testing Market, By End User
7.3.3 Europe Early Toxicity Testing, Market By Country
7.3.3.1 Germany
7.3.3.1.1 Germany Early Toxicity Testing Market, By Technique
7.3.3.1.1.1. Germany In Vitro Market, By Technique
7.3.3.1.2 Germany Early Toxicity Testing Market, By End User
7.3.3.2 France
7.3.3.2.1 France Early Toxicity Testing Market, By Technique
7.3.3.2.1.1. France In Vitro Market, By Technique
7.3.3.2.2 France Early Toxicity Testing Market, By End User
7.3.3.3 UK
7.3.3.3.1 UK Early Toxicity Testing Market, By Technique
7.3.3.3.1.1. UK In Vitro Market, By Technique
7.3.3.3.2 UK Early Toxicity Testing Market, By End User
7.3.3.4 Rest of Europe
7.3.3.4.1 Rest of Europe Early Toxicity Testing Market, By Technique
7.3.3.4.1.1. Rest of Europe In Vitro Market, By Technique
7.3.3.4.2 Rest of Europe Early Toxicity Testing Market, By End User
7.4. Asia-Pacific
7.4.1 Asia-Pacific Early Toxicity Testing Market, By Technique
7.4.1.1 Asia-Pacific In Vitro Market, By Technique
7.4.2 Asia-Pacific Early Toxicity Testing Market, By End User
7.4.3 Asia-Pacific Early Toxicity Testing, Market By Country
7.4.3.1 India
7.4.3.1.1 India Early Toxicity Testing Market, By Technique
7.4.3.1.1.1. India In Vitro Market, By Technique
7.4.3.1.2 India Early Toxicity Testing Market, By End User
7.4.3.2 China
7.4.3.2.1 China Early Toxicity Testing Market, By Technique
7.4.3.2.1.1. China In Vitro Market, By Technique
7.4.3.2.2 China Early Toxicity Testing Market, By End User
7.4.3.3 Japan
7.4.3.3.1 Japan Early Toxicity Testing Market, By Technique
7.4.3.3.1.1. Japan In Vitro Market, By Technique
7.4.3.3.2 Japan Early Toxicity Testing Market, By End User
7.4.3.4 Australia
7.4.3.4.1 Australia Early Toxicity Testing Market, By Technique
7.4.3.4.1.1. Australia In Vitro Market, By Technique
7.4.3.4.2 Australia Early Toxicity Testing Market, By End User
7.4.3.5 Rest of APAC
7.4.3.5.1 Rest of APAC Early Toxicity Testing Market, By Technique
7.4.3.5.1.1. Rest of APAC In Vitro Market, By Technique
7.4.3.5.2 Rest of APAC Early Toxicity Testing Market, By End User
7.5. Rest of World
7.5.1 Rest of World Early Toxicity Testing Market, By Technique
7.5.1.1 Rest of World In Vitro Market, By Technique
7.5.2 Rest of World Early Toxicity Testing Market, By End User
7.5.3 Rest of World Early Toxicity Testing, Market By Country
7.5.3.1 Brazil
7.5.3.1.1 Brazil Early Toxicity Testing Market, By Technique
7.5.3.1.1.1. Brazil In Vitro Market, By Technique
7.5.3.1.2 Brazil Early Toxicity Testing Market, By End User
7.5.3.2 South Africa
7.5.3.2.1 South Africa Early Toxicity Testing Market, By Technique
7.5.3.2.1.1. South Africa In Vitro Market, By Technique
7.5.3.2.2 South Africa Early Toxicity Testing Market, By End User
7.5.3.3 UAE
7.5.3.3.1 UAE Early Toxicity Testing Market, By Technique
7.5.3.3.1.1. UAE In Vitro Market, By Technique
7.5.3.3.2 UAE Early Toxicity Testing Market, By End User
7.5.3.4 Remaining Countries
7.5.3.4.1 Remaining Countries Early Toxicity Testing Market, By Technique
7.5.3.4.1.1. Remaining Countries In Vitro Market, By Technique
7.5.3.4.2 Remaining Countries Early Toxicity Testing Market, By End User
8. COMPANY PROFILES
8.1. AGILENT TECHNOLOGIES, INC.
8.1.1 COMPANY OVERVIEW
8.1.2 COMPANY SNAPSHOT
8.1.3 OPERATING BUSINESS SEGMENTS
8.1.4 PRODUCT PORTFOLIO
8.1.5 BUSINESS PERFORMANCE
8.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.2. BIOANALYTICAL SYSTEMS, INC.
8.2.1 COMPANY OVERVIEW
8.2.2 COMPANY SNAPSHOT
8.2.3 OPERATING BUSINESS SEGMENTS
8.2.4 PRODUCT PORTFOLIO
8.2.5 BUSINESS PERFORMANCE
8.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.3. BRUKER CORPORATION
8.3.1 COMPANY OVERVIEW
8.3.2 COMPANY SNAPSHOT
8.3.3 OPERATING BUSINESS SEGMENTS
8.3.4 PRODUCT PORTFOLIO
8.3.5 BUSINESS PERFORMANCE
8.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.4. DANAHER CORPORATION
8.4.1 COMPANY OVERVIEW
8.4.2 COMPANY SNAPSHOT
8.4.3 OPERATING BUSINESS SEGMENTS
8.4.4 PRODUCT PORTFOLIO
8.4.5 BUSINESS PERFORMANCE
8.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.5. EVOTEC AG
8.5.1 COMPANY OVERVIEW
8.5.2 COMPANY SNAPSHOT
8.5.3 OPERATING BUSINESS SEGMENTS
8.5.4 PRODUCT PORTFOLIO
8.5.5 BUSINESS PERFORMANCE
8.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.6. ENZO BIOCHEM, INC.
8.6.1 COMPANY OVERVIEW
8.6.2 COMPANY SNAPSHOT
8.6.3 OPERATING BUSINESS SEGMENTS
8.6.4 PRODUCT PORTFOLIO
8.6.5 BUSINESS PERFORMANCE
8.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.7. GENERAL ELECTRIC COMPANY
8.7.1 COMPANY OVERVIEW
8.7.2 COMPANY SNAPSHOT
8.7.3 OPERATING BUSINESS SEGMENTS
8.7.4 PRODUCT PORTFOLIO
8.7.5 BUSINESS PERFORMANCE
8.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.8. MYRIAD GENETICS, INC.
8.8.1 COMPANY OVERVIEW
8.8.2 COMPANY SNAPSHOT
8.8.3 OPERATING BUSINESS SEGMENTS
8.8.4 PRODUCT PORTFOLIO
8.8.5 BUSINESS PERFORMANCE
8.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.9. PERKINELMER INC.
8.9.1 COMPANY OVERVIEW
8.9.2 COMPANY SNAPSHOT
8.9.3 OPERATING BUSINESS SEGMENTS
8.9.4 PRODUCT PORTFOLIO
8.9.5 BUSINESS PERFORMANCE
8.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT
8.10. THERMO FISHER SCIENTIFIC, INC.
8.10.1 COMPANY OVERVIEW
8.10.2 COMPANY SNAPSHOT
8.10.3 OPERATING BUSINESS SEGMENTS
8.10.4 PRODUCT PORTFOLIO
8.10.5 BUSINESS PERFORMANCE
8.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT
TABLE 1. Global Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 2. In Vivo Market Value, By Region, 2019-2030, Million USD
TABLE 3. North America In Vivo Market Value, By Country, 2019-2030, Million USD
TABLE 4. Europe In Vivo Market Value, By Country, 2019-2030, Million USD
TABLE 5. Asia-Pacific In Vivo Market Value, By Country, 2019-2030, Million USD
TABLE 6. Rest of World In Vivo Market Value, By Country, 2019-2030, Million USD
TABLE 7. Global In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 8. Assays Market Value, By Region, 2019-2030, Million USD
TABLE 9. North America Assays Market Value, By Country, 2019-2030, Million USD
TABLE 10. Europe Assays Market Value, By Country, 2019-2030, Million USD
TABLE 11. Asia-Pacific Assays Market Value, By Country, 2019-2030, Million USD
TABLE 12. Rest of World Assays Market Value, By Country, 2019-2030, Million USD
TABLE 13. Toxicity End points Market Value, By Region, 2019-2030, Million USD
TABLE 14. North America Toxicity End points Market Value, By Country, 2019-2030, Million USD
TABLE 15. Europe Toxicity End points Market Value, By Country, 2019-2030, Million USD
TABLE 16. Asia-Pacific Toxicity End points Market Value, By Country, 2019-2030, Million USD
TABLE 17. Rest of World Toxicity End points Market Value, By Country, 2019-2030, Million USD
TABLE 18. In Vitro Market Value, By Region, 2019-2030, Million USD
TABLE 19. North America In Vitro Market Value, By Country, 2019-2030, Million USD
TABLE 20. Europe In Vitro Market Value, By Country, 2019-2030, Million USD
TABLE 21. Asia-Pacific In Vitro Market Value, By Country, 2019-2030, Million USD
TABLE 22. Rest of World In Vitro Market Value, By Country, 2019-2030, Million USD
TABLE 23. In Silico Market Value, By Region, 2019-2030, Million USD
TABLE 24. North America In Silico Market Value, By Country, 2019-2030, Million USD
TABLE 25. Europe In Silico Market Value, By Country, 2019-2030, Million USD
TABLE 26. Asia-Pacific In Silico Market Value, By Country, 2019-2030, Million USD
TABLE 27. Rest of World In Silico Market Value, By Country, 2019-2030, Million USD
TABLE 28. Global Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 29. Pharmaceuticals Industry Market Value, By Region, 2019-2030, Million USD
TABLE 30. North America Pharmaceuticals Industry Market Value, By Country, 2019-2030, Million USD
TABLE 31. Europe Pharmaceuticals Industry Market Value, By Country, 2019-2030, Million USD
TABLE 32. Asia-Pacific Pharmaceuticals Industry Market Value, By Country, 2019-2030, Million USD
TABLE 33. Rest of World Pharmaceuticals Industry Market Value, By Country, 2019-2030, Million USD
TABLE 34. Diagnostics Industry Market Value, By Region, 2019-2030, Million USD
TABLE 35. North America Diagnostics Industry Market Value, By Country, 2019-2030, Million USD
TABLE 36. Europe Diagnostics Industry Market Value, By Country, 2019-2030, Million USD
TABLE 37. Asia-Pacific Diagnostics Industry Market Value, By Country, 2019-2030, Million USD
TABLE 38. Rest of World Diagnostics Industry Market Value, By Country, 2019-2030, Million USD
TABLE 39. Food Industry Market Value, By Region, 2019-2030, Million USD
TABLE 40. North America Food Industry Market Value, By Country, 2019-2030, Million USD
TABLE 41. Europe Food Industry Market Value, By Country, 2019-2030, Million USD
TABLE 42. Asia-Pacific Food Industry Market Value, By Country, 2019-2030, Million USD
TABLE 43. Rest of World Food Industry Market Value, By Country, 2019-2030, Million USD
TABLE 44. Chemicals Industry Market Value, By Region, 2019-2030, Million USD
TABLE 45. North America Chemicals Industry Market Value, By Country, 2019-2030, Million USD
TABLE 46. Europe Chemicals Industry Market Value, By Country, 2019-2030, Million USD
TABLE 47. Asia-Pacific Chemicals Industry Market Value, By Country, 2019-2030, Million USD
TABLE 48. Rest of World Chemicals Industry Market Value, By Country, 2019-2030, Million USD
TABLE 49. Cosmetics Industry Market Value, By Region, 2019-2030, Million USD
TABLE 50. North America Cosmetics Industry Market Value, By Country, 2019-2030, Million USD
TABLE 51. Europe Cosmetics Industry Market Value, By Country, 2019-2030, Million USD
TABLE 52. Asia-Pacific Cosmetics Industry Market Value, By Country, 2019-2030, Million USD
TABLE 53. Rest of World Cosmetics Industry Market Value, By Country, 2019-2030, Million USD
TABLE 54. Others Market Value, By Region, 2019-2030, Million USD
TABLE 55. North America Others Market Value, By Country, 2019-2030, Million USD
TABLE 56. Europe Others Market Value, By Country, 2019-2030, Million USD
TABLE 57. Asia-Pacific Others Market Value, By Country, 2019-2030, Million USD
TABLE 58. Rest of World Others Market Value, By Country, 2019-2030, Million USD
TABLE 59. Global Early Toxicity Testing Market Value, By Region, 2019-2030, Million USD
TABLE 60. North America Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 61. North America In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 62. North America Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 63. U.S. Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 64. U.S. In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 65. U.S. Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 66. Canada Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 67. Canada In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 68. Canada Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 69. Mexico Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 70. Mexico In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 71. Mexico Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 72. Europe Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 73. Europe In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 74. Europe Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 75. Germany Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 76. Germany In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 77. Germany Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 78. France Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 79. France In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 80. France Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 81. UK Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 82. UK In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 83. UK Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 84. Rest of Europe Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 85. Rest of Europe In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 86. Rest of Europe Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 87. Asia-Pacific Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 88. Asia-Pacific In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 89. Asia-Pacific Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 90. India Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 91. India In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 92. India Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 93. China Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 94. China In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 95. China Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 96. Japan Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 97. Japan In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 98. Japan Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 99. Australia Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 100. Australia In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 101. Australia Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 102. Rest of APAC Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 103. Rest of APAC In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 104. Rest of APAC Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 105. Rest of World Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 106. Rest of World In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 107. Rest of World Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 108. Brazil Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 109. Brazil In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 110. Brazil Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 111. South Africa Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 112. South Africa In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 113. South Africa Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 114. UAE Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 115. UAE In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 116. UAE Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 117. Remaining Countries Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
TABLE 118. Remaining Countries In Vitro Market Value, By Technique, 2019-2030, Million USD
TABLE 119. Remaining Countries Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
TABLE 120. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 121. AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 122. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 123. AGILENT TECHNOLOGIES, INC.: KEY STRATERGY
TABLE 124. BIOANALYTICAL SYSTEMS, INC.: COMPANY SNAPSHOT
TABLE 125. BIOANALYTICAL SYSTEMS, INC.: OPERATING SEGMENTS
TABLE 126. BIOANALYTICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
TABLE 127. BIOANALYTICAL SYSTEMS, INC.: KEY STRATERGY
TABLE 128. BRUKER CORPORATION: COMPANY SNAPSHOT
TABLE 129. BRUKER CORPORATION: OPERATING SEGMENTS
TABLE 130. BRUKER CORPORATION: PRODUCT PORTFOLIO
TABLE 131. BRUKER CORPORATION: KEY STRATERGY
TABLE 132. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 133. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 134. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 135. DANAHER CORPORATION: KEY STRATERGY
TABLE 136. EVOTEC AG: COMPANY SNAPSHOT
TABLE 137. EVOTEC AG: OPERATING SEGMENTS
TABLE 138. EVOTEC AG: PRODUCT PORTFOLIO
TABLE 139. EVOTEC AG: KEY STRATERGY
TABLE 140. ENZO BIOCHEM, INC.: COMPANY SNAPSHOT
TABLE 141. ENZO BIOCHEM, INC.: OPERATING SEGMENTS
TABLE 142. ENZO BIOCHEM, INC.: PRODUCT PORTFOLIO
TABLE 143. ENZO BIOCHEM, INC.: KEY STRATERGY
TABLE 144. GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
TABLE 145. GENERAL ELECTRIC COMPANY: OPERATING SEGMENTS
TABLE 146. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
TABLE 147. GENERAL ELECTRIC COMPANY: KEY STRATERGY
TABLE 148. MYRIAD GENETICS, INC.: COMPANY SNAPSHOT
TABLE 149. MYRIAD GENETICS, INC.: OPERATING SEGMENTS
TABLE 150. MYRIAD GENETICS, INC.: PRODUCT PORTFOLIO
TABLE 151. MYRIAD GENETICS, INC.: KEY STRATERGY
TABLE 152. PERKINELMER INC.: COMPANY SNAPSHOT
TABLE 153. PERKINELMER INC.: OPERATING SEGMENTS
TABLE 154. PERKINELMER INC.: PRODUCT PORTFOLIO
TABLE 155. PERKINELMER INC.: KEY STRATERGY
TABLE 156. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 157. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 158. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 159. THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGY
LIST OF FIGURES
FIGURE 1. Global Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 2. In Vivo Market Value, By Region, 2019-2030, Million USD
FIGURE 3. North America In Vivo Market Value, By Country, 2019-2030, Million USD
FIGURE 4. Europe In Vivo Market Value, By Country, 2019-2030, Million USD
FIGURE 5. Asia-Pacific In Vivo Market Value, By Country, 2019-2030, Million USD
FIGURE 6. Rest of World In Vivo Market Value, By Country, 2019-2030, Million USD
FIGURE 7. Global In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 8. Assays Market Value, By Region, 2019-2030, Million USD
FIGURE 9. North America Assays Market Value, By Country, 2019-2030, Million USD
FIGURE 10. Europe Assays Market Value, By Country, 2019-2030, Million USD
FIGURE 11. Asia-Pacific Assays Market Value, By Country, 2019-2030, Million USD
FIGURE 12. Rest of World Assays Market Value, By Country, 2019-2030, Million USD
FIGURE 13. Toxicity End points Market Value, By Region, 2019-2030, Million USD
FIGURE 14. North America Toxicity End points Market Value, By Country, 2019-2030, Million USD
FIGURE 15. Europe Toxicity End points Market Value, By Country, 2019-2030, Million USD
FIGURE 16. Asia-Pacific Toxicity End points Market Value, By Country, 2019-2030, Million USD
FIGURE 17. Rest of World Toxicity End points Market Value, By Country, 2019-2030, Million USD
FIGURE 18. In Vitro Market Value, By Region, 2019-2030, Million USD
FIGURE 19. North America In Vitro Market Value, By Country, 2019-2030, Million USD
FIGURE 20. Europe In Vitro Market Value, By Country, 2019-2030, Million USD
FIGURE 21. Asia-Pacific In Vitro Market Value, By Country, 2019-2030, Million USD
FIGURE 22. Rest of World In Vitro Market Value, By Country, 2019-2030, Million USD
FIGURE 23. In Silico Market Value, By Region, 2019-2030, Million USD
FIGURE 24. North America In Silico Market Value, By Country, 2019-2030, Million USD
FIGURE 25. Europe In Silico Market Value, By Country, 2019-2030, Million USD
FIGURE 26. Asia-Pacific In Silico Market Value, By Country, 2019-2030, Million USD
FIGURE 27. Rest of World In Silico Market Value, By Country, 2019-2030, Million USD
FIGURE 28. Global Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 29. Pharmaceuticals Industry Market Value, By Region, 2019-2030, Million USD
FIGURE 30. North America Pharmaceuticals Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 31. Europe Pharmaceuticals Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 32. Asia-Pacific Pharmaceuticals Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 33. Rest of World Pharmaceuticals Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 34. Diagnostics Industry Market Value, By Region, 2019-2030, Million USD
FIGURE 35. North America Diagnostics Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 36. Europe Diagnostics Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 37. Asia-Pacific Diagnostics Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 38. Rest of World Diagnostics Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 39. Food Industry Market Value, By Region, 2019-2030, Million USD
FIGURE 40. North America Food Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 41. Europe Food Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 42. Asia-Pacific Food Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 43. Rest of World Food Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 44. Chemicals Industry Market Value, By Region, 2019-2030, Million USD
FIGURE 45. North America Chemicals Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 46. Europe Chemicals Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 47. Asia-Pacific Chemicals Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 48. Rest of World Chemicals Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 49. Cosmetics Industry Market Value, By Region, 2019-2030, Million USD
FIGURE 50. North America Cosmetics Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 51. Europe Cosmetics Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 52. Asia-Pacific Cosmetics Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 53. Rest of World Cosmetics Industry Market Value, By Country, 2019-2030, Million USD
FIGURE 54. Others Market Value, By Region, 2019-2030, Million USD
FIGURE 55. North America Others Market Value, By Country, 2019-2030, Million USD
FIGURE 56. Europe Others Market Value, By Country, 2019-2030, Million USD
FIGURE 57. Asia-Pacific Others Market Value, By Country, 2019-2030, Million USD
FIGURE 58. Rest of World Others Market Value, By Country, 2019-2030, Million USD
FIGURE 59. Global Early Toxicity Testing Market Value, By Region, 2019-2030, Million USD
FIGURE 60. North America Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 61. North America In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 62. North America Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 63. U.S. Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 64. U.S. In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 65. U.S. Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 66. Canada Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 67. Canada In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 68. Canada Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 69. Mexico Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 70. Mexico In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 71. Mexico Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 72. Europe Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 73. Europe In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 74. Europe Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 75. Germany Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 76. Germany In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 77. Germany Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 78. France Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 79. France In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 80. France Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 81. UK Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 82. UK In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 83. UK Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 84. Rest of Europe Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 85. Rest of Europe In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 86. Rest of Europe Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 87. Asia-Pacific Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 88. Asia-Pacific In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 89. Asia-Pacific Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 90. India Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 91. India In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 92. India Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 93. China Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 94. China In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 95. China Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 96. Japan Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 97. Japan In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 98. Japan Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 99. Australia Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 100. Australia In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 101. Australia Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 102. Rest of APAC Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 103. Rest of APAC In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 104. Rest of APAC Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 105. Rest of World Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 106. Rest of World In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 107. Rest of World Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 108. Brazil Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 109. Brazil In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 110. Brazil Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 111. South Africa Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 112. South Africa In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 113. South Africa Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 114. UAE Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 115. UAE In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 116. UAE Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 117. Remaining Countries Early Toxicity Testing Market Value, By Technique, 2019-2030, Million USD
FIGURE 118. Remaining Countries In Vitro Market Value, By Technique, 2019-2030, Million USD
FIGURE 119. Remaining Countries Early Toxicity Testing Market Value, By End User, 2019-2030, Million USD
FIGURE 120. AGILENT TECHNOLOGIES, INC.: NET SALES,2018-2020
FIGURE 121. BIOANALYTICAL SYSTEMS, INC.: NET SALES,2018-2020
FIGURE 122. BRUKER CORPORATION: NET SALES,2018-2020
FIGURE 123. DANAHER CORPORATION: NET SALES,2018-2020
FIGURE 124. EVOTEC AG: NET SALES,2018-2020
FIGURE 125. ENZO BIOCHEM, INC.: NET SALES,2018-2020
FIGURE 126. GENERAL ELECTRIC COMPANY: NET SALES,2018-2020
FIGURE 127. MYRIAD GENETICS, INC.: NET SALES,2018-2020
FIGURE 128. PERKINELMER INC.: NET SALES,2018-2020
FIGURE 129. THERMO FISHER SCIENTIFIC, INC.: NET SALES,2018-2020